EXEL CIK: 939767

Exelixis Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.83
FY22:
1.62
FY23:
1.32
FY24:
1.47
FY25:
1.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
1.45
FY23:
1.62
FY24:
1.48
FY25:
1.40
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.62
FY22:
3.07
FY23:
2.94
FY24:
2.95
FY25:
2.84

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.32
FY23:
0.39
FY24:
0.40
FY25:
0.41
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.26
FY23:
0.28
FY24:
0.30
FY25:
0.28
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.21
FY22:
2.49
FY23:
2.26
FY24:
2.24
FY25:
2.16
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.62
FY22:
3.07
FY23:
2.94
FY24:
2.95
FY25:
2.84

All amounts in billions USD Data source:SEC EDGAR